Brief: Getinge's Subsidiary Maquet Cardiovascular Receives Adverse Jury Trial Verdict In Patent Infringement Dispute With Abiomed In U.S.
28/05/2026 17:38
BRIEF-Getinge's Subsidiary Maquet Cardiovascular Receives Adverse Jury Trial Verdict In Patent Infringement Dispute With Abiomed In U.S. May 28 (Reuters) - Getinge publ AB GETIb.ST:
GETINGE'S SUBSIDIARY MAQUET CARDIOVASCULAR RECEIVES ADVERSE JURY TRIAL VERDICT IN PATENT INFRINGEMENT DISPUTE WITH ABIOMED IN U.S.
GETINGE - VERDICT DOES NOT HAVE ANY NEGATIVE FINANCIAL OR OPERATIONAL IMPACT ON GETINGE
GETINGE: JURY FOUND THAT ABIOMED HAS NOT INFRINGED ANY MAQUET PATENTS RELATING TO INTRAVASCULAR HEART PUMP TECHNOLOGY
Source text: ID:nNDL8TczxD
Further company coverage: [GETIb.ST]
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Getinge publ AB
See all newsBrief: CEO Buys SEK 4.7 Million Of Getinge Shares
Johnson & Johnson defeats heart-pump patent claims in US trial (updated)
Johnson & Johnson defeats heart-pump patent claims in US trial
Brief: Getinge's Subsidiary Maquet Cardiovascular Receives Adverse Jury Trial Verdict In Patent Infringement Dispute With Abiomed In U.S.
Getinge lags profit estimates as uncertainty curbs investments in medical equipment